Today's Date: June 3, 2023
Bijou Ikli named new CEO by Florida Assisted Living Association   •   Castle Biosciences to Share New Data on DecisionDx®-Melanoma and DecisionDx®-UM at the 2023 ASCO Annual Meeting   •   Preliminary Ongoing Results with CYT-0851 in Combination with Capecitabine or Gemcitabine in Advanced Solid Tumors Show Early Cl   •   Massive Bio and The Oncology Institute (TOI) Forge Partnership to Revolutionize Cancer Care and AI-enabled Cancer Research   •   Statement from Minister Hutchings on progress in support of rural Canadians   •   Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Investigation of SentinelOne, Inc. (S) on Behalf   •   56 Trilogy Health Services Communities Earn 2023 AHCA/NCAL Bronze National Quality Award   •   Air Canada's Inaugural Amsterdam-Montreal Route Takes Off; Uplifts Sustainable Aviation Fuel in Amsterdam   •   The Patient Safety Movement Foundation Concludes Its 10th Annual World Patient Safety, Science & Technology Summit   •   Rapid Dose Announces Proposed Private Placement Financing   •   The Assembly of First Nations and the Government of Canada announce updates to school design standards for schools on-reserve   •   Promoting Diversity and Equity in Cancer Research, Women Leaders in Oncology® and Vaniam Group Announce Recipients of 2023 Y   •   Statement by the Prime Minister to mark four years since the publication of the final report of the National Inquiry into Missin   •   Exai Bio Presents New Multi-Cancer Early Detection Data at the American Society of Clinical Oncology (ASCO) 2023 Annual Meeting   •   San Francisco Pride Announces Headliners Hayley Kiyoko and Princess Nokia for 53rd Annual SF Pride Parade & Celebration Feat   •   Merck’s KEYTRUDA® (pembrolizumab) Plus Chemotherapy Before Surgery and Continued as a Single Agent After Surgery   •   High Schooler empowers Youth with Nonprofit "Unlimited Potential", raises $100,000 for Sports Medicine Research and Advocacy   •   UNice Celebrates LGBTQ Pride Month   •   KEYTRUDA® (pembrolizumab) Plus Chemotherapy Significantly Improved Overall Survival Versus Chemotherapy Alone as First-Line   •   LYNPARZA® (olaparib) and IMFINZI® (durvalumab) combination reduced risk of disease progression or death by 37% vs. chemo
Bookmark and Share

ESO’s Dr. Brent Myers Receives Notable Recognition for Revolutionary Impact on EMS, awarded by the American College of Eme

AUSTIN, Texas , May 26 /Businesswire/ - ESO, the leading data and software company serving emergency medical services (EMS), fire departments, hospitals, and state EMS/Trauma offices, today announced Dr. Brent Myers, Chief Medical Officer at ESO, received the Outstanding Contribution in EMS award by the American College of Emergency Physicians.

"Dr. Brent Myers' dedication and contributions to improving patient outcomes in the prehospital setting are truly unparalleled," said Eric Beck, DO, MPH, FACEP, President at ESO. "Through groundbreaking research and thought leadership, Dr. Myers has made a profound impact on public health and played a vital role in shaping the prehospital medical environment, ensuring equitable and accurate care for patients. His unwavering advocacy and expert guidance for clinicians nationwide have been instrumental in advancing EMS practices."

The American College of Emergency Physicians Awards Program honors exemplary leaders in the healthcare field who demonstrate outstanding excellence. This prestigious program serves as a platform to acknowledge ACEP members for their significant professional contributions.

"True progress in the prehospital environment requires dedication and a commitment to research and innovation," continued Beck. "By reviewing thousands of patient outcomes, Dr. Brent Myers and his team are unlocking invaluable insights that have the power to transform EMS practices. It is through his commitment that ESO can continue its mission to improve community health and safety through the power of data. These are life-saving practices that Dr. Myers works to improve every day."

To see more of the work Dr. Brent Myers and his research colleagues contribute to the public health and safety dialogue, visit: https://www.eso.com/data-and-research/

About ESO

ESO (ESO Solutions, Inc.) is dedicated to improving community health and safety through the power of data. Since its founding in 2004, the company continues to pioneer innovative, user-friendly software to meet the changing needs of today’s EMS agencies, fire departments, hospitals and state EMS offices. ESO currently serves thousands of customers throughout North America with a broad software portfolio, including the industry-leading ESO Electronic Health Record (EHR), the next generation ePCR; ESO Health Data Exchange (HDE), the first-of-its-kind healthcare interoperability platform; ESO Fire RMS, the gold standard for fire Record Management Systems; trauma, burn and stroke registry software; and ESO State Repository. ESO is headquartered in Austin, Texas. For more information, visit www.eso.com.


STORY TAGS: Personnel, Award, Technology, Hospitals, Law Enforcement/Emergency Services, Public Policy/Government, Health Technology, Software, Managed Care, Health, Data Management, United States, North America, Texas,

Video

White House Live Stream
LIVE VIDEO EVERY SATURDAY
Breaking News
alsharpton Rev. Al Sharpton
9 to 11 am EST
jjackson Rev. Jesse Jackson
10 to noon CST


Video

LIVE BROADCASTS
Sounds Make the News ®
WAOK-Urban
Atlanta - WAOK-Urban
KPFA-Progressive
Berkley / San Francisco - KPFA-Progressive
WVON-Urban
Chicago - WVON-Urban
KJLH - Urban
Los Angeles - KJLH - Urban
WKDM-Mandarin Chinese
New York - WKDM-Mandarin Chinese
WADO-Spanish
New York - WADO-Spanish
WBAI - Progressive
New York - WBAI - Progressive
WOL-Urban
Washington - WOL-Urban

Listen to United Natiosns News